Barinthus Biotherapeutics plc. (BRNS) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$0

Net Income/Loss (FY2025)

-$66.5M

Total Assets (FY2025)

$98.2M

Total Equity (FY2025)

$74.3M

Cash Flows from Operating Activities (FY2025)

-$48.0M

Source: Barinthus Biotherapeutics plc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.